CI

At a glance

ClinicalIndex Comparison Record
N/AActive· 168 enrolled
Drug / intervention
DHA +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02647723
NCT02647723N/AActive

Improving Maternal and Child Health Through Prenatal Fatty Acid Supplementation: A Randomized Controlled Study in African American Women Living in Low-income Urban Environments

University of Chicago·interventional·Posted Jan 6, 2016·Updated May 27, 2026

In Brief

A clinical study evaluating DHA and Sugar pill for Pregnancy and Child Development. Active but no longer recruiting, targeting 168 participants across 1 site.

Detailed Summary

The purpose of the study is to test whether nutritional supplementation during pregnancy is associated with 1) improved maternal health during pregnancy; 2) improved infant birth and neurodevelopmental outcomes, and 3) whether the association between nutritional supplementation during pregnancy and infant outcomes is partially mediated by reductions in maternal perceived stress and stress reactivity during pregnancy.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/AActive
2016201720182019202020212022202320242025202620272028
First PostedJan 6, 2016
Enrollment StartJan 1, 2016
Primary CompletionDec 31, 2027
TodayJul 2, 2026
Enrollment to primary: 12 yearsPosted 10.5 years agoPrimary completion in 1.5 years

Interventions

DHAdietary

2 dietary supplement gel capsules providing 450 mg of DHA twice daily by oral intake for 24 weeks

Sugar pilldietary

2 dietary supplement gel capsules providing 450 mg of soybean oil twice daily by oral intake for 24 weeks